The precautionary recall of CosmoFer® has been resolved

December 8, 2008

Pharmacosmos is pleased to inform that the precautionary recall has been resolved. New CosmoFer® batches are currently being supplied to hospitals and healthcare clinics.

About Pharmacosmos A/S

Pharmacosmos develops and markets medicines for the treatment of iron deficiency. A research-based company, its ongoing R&D programme focuses on improving the treatment options for healthcare professionals and patients suffering from iron deficiency.

Pharmacosmos is a privately-owned Danish company and operates in more than 50 countries across Europe, the Americas and Asia. Its facilities are approved by the Danish Medicines Agency and the US Food & Drug Administration.